Proteomics Approaches to Define Senescence Heterogeneity and Chemotherapy Response

Abstract : In primary cells, senescence induces a permanent proliferative arrest to prevent the propagation of malignant cells. However, the outcome of senescence is more complex in advanced cancer cells where senescent states are heterogeneous. Here, this heterogeneity is discussed and it is proposed that proteomic analysis should be used to identify specific signatures of cancer cells that use this pathway as an adaptive mechanism. Since senescent cells produce an inflammatory secretome, MRM approaches and quantification with internal standards might be particularly suited to follow the expression of the corresponding markers in body fluids. Used in combination with imaging medical technics, a better characterization of senescence heterogeneity should help to monitor the response to chemotherapy treatment.
Document type :
Journal articles
Complete list of metadatas

Cited literature [36 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-02140239
Contributor : Elizabeth Bernardo <>
Submitted on : Monday, May 27, 2019 - 10:30:34 AM
Last modification on : Tuesday, May 28, 2019 - 1:50:06 AM

File

 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document

Identifiers

Collections

Citation

Coralie Petit, Jordan Guillon, Bertrand Toutain, Alice Boissard, Anne Patsouris, et al.. Proteomics Approaches to Define Senescence Heterogeneity and Chemotherapy Response. Proteomics, Wiley-VCH Verlag, 2019, pp.1800447. ⟨10.1002/pmic.201800447⟩. ⟨inserm-02140239⟩

Share

Metrics

Record views

59